Cargando…
Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
SIMPLE SUMMARY: Early-stage and castration-sensitive prostate cancer (PCa) growth is solely mediated by androgen signaling pathways. AR signaling inhibitors (ARSIs) have significantly improved clinical outcomes among men with PCa. In the metastatic castration-resistant PCa, there is presence of both...
Autores principales: | Jacob, Aasems, Raj, Rishi, Allison, Derek B., Myint, Zin W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582395/ https://www.ncbi.nlm.nih.gov/pubmed/34771580 http://dx.doi.org/10.3390/cancers13215417 |
Ejemplares similares
-
Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review
por: Raj, Rishi, et al.
Publicado: (2021) -
Androgen Receptor Signalling in Prostate Cancer: The Functional Consequences of Acetylation
por: Lavery, Derek N., et al.
Publicado: (2011) -
A Case Report of Metastatic Castration-Resistant Prostate Cancer Harboring a PTEN Loss
por: Myint, Zin W., et al.
Publicado: (2021) -
Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Jillson, Lauren K., et al.
Publicado: (2021) -
Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials
por: Chung, Wei-Min, et al.
Publicado: (2021)